Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.

Means AL, Freeman TJ, Zhu J, Woodbury LG, Marincola-Smith P, Wu C, Meyer AR, Weaver CJ, Padmanabhan C, An H, Zi J, Wessinger BC, Chaturvedi R, Brown TD, Deane NG, Coffey RJ, Wilson KT, Smith JJ, Sawyers CL, Goldenring JR, Novitskiy SV, Washington MK, Shi C, Beauchamp RD.

Cell Mol Gastroenterol Hepatol. 2018 May 24;6(3):257-276. doi: 10.1016/j.jcmgh.2018.05.006. eCollection 2018.

2.

Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples.

Zhu J, Deane NG, Lewis KB, Padmanabhan C, Washington MK, Ciombor KK, Timmers C, Goldberg RM, Beauchamp RD, Chen X.

Sci Rep. 2016 Sep 14;6:33273. doi: 10.1038/srep33273.

3.

Comparison of Nanostring nCounter® Data on FFPE Colon Cancer Samples and Affymetrix Microarray Data on Matched Frozen Tissues.

Chen X, Deane NG, Lewis KB, Li J, Zhu J, Washington MK, Beauchamp RD.

PLoS One. 2016 May 13;11(5):e0153784. doi: 10.1371/journal.pone.0153784. eCollection 2016.

4.

The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia.

Salleng KJ, Revetta FL, Deane NG, Washington MK.

Comp Med. 2015 Oct;65(5):398-408.

5.

Linking patient outcome to high throughput protein expression data identifies novel regulators of colorectal adenocarcinoma aggressiveness.

French CL, Ye F, Revetta F, Zhang B, Coffey RJ, Washington MK, Deane NG, Beauchamp RD, Weaver AM.

F1000Res. 2015 Apr 24;4:99. doi: 10.12688/f1000research.6388.1. eCollection 2015.

6.

Small molecule/ML327 mediated transcriptional de-repression of E-cadherin and inhibition of epithelial-to-mesenchymal transition.

An H, Stoops SL, Deane NG, Zhu J, Zi J, Weaver C, Waterson AG, Zijlstra A, Lindsley CW, Beauchamp RD.

Oncotarget. 2015 Sep 8;6(26):22934-48.

7.

Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer.

Tripathi MK, Deane NG, Zhu J, An H, Mima S, Wang X, Padmanabhan S, Shi Z, Prodduturi N, Ciombor KK, Chen X, Washington MK, Zhang B, Beauchamp RD.

Cancer Res. 2014 Dec 1;74(23):6947-57. doi: 10.1158/0008-5472.CAN-14-1592. Epub 2014 Oct 15.

8.

Deciphering genomic alterations in colorectal cancer through transcriptional subtype-based network analysis.

Zhu J, Wang J, Shi Z, Franklin JL, Deane NG, Coffey RJ, Beauchamp RD, Zhang B.

PLoS One. 2013 Nov 15;8(11):e79282. doi: 10.1371/journal.pone.0079282. eCollection 2013.

9.

Transforming growth factor ╬▓ regulates P-body formation through induction of the mRNA decay factor tristetraprolin.

Blanco FF, Sanduja S, Deane NG, Blackshear PJ, Dixon DA.

Mol Cell Biol. 2014 Jan;34(2):180-95. doi: 10.1128/MCB.01020-13. Epub 2013 Nov 4.

10.

Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma.

Al-Greene NT, Means AL, Lu P, Jiang A, Schmidt CR, Chakravarthy AB, Merchant NB, Washington MK, Zhang B, Shyr Y, Deane NG, Beauchamp RD.

PLoS One. 2013 Jul 29;8(7):e69660. doi: 10.1371/journal.pone.0069660. Print 2013.

11.

Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of ╬▓-catenin.

Freeman TJ, Smith JJ, Chen X, Washington MK, Roland JT, Means AL, Eschrich SA, Yeatman TJ, Deane NG, Beauchamp RD.

Gastroenterology. 2012 Mar;142(3):562-571.e2. doi: 10.1053/j.gastro.2011.11.026. Epub 2011 Nov 22.

12.

Modeling tumor growth and treatment response based on quantitative imaging data.

Yankeelov TE, Atuegwu NC, Deane NG, Gore JC.

Integr Biol (Camb). 2010 Aug;2(7-8):338-45. doi: 10.1039/b921497f. Epub 2010 Jul 2. Review.

13.

A novel in vitro assay to assess phosphorylation of 3'-[(18)F]fluoro-3'-deoxythymidine.

Guo N, Xie J, Manning HC, Deane NG, Ansari MS, Coffey RJ, Gore J, Price RR, Baldwin RM, McIntyre JO.

Mol Imaging Biol. 2011 Apr;13(2):257-64. doi: 10.1007/s11307-010-0351-8.

14.

Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer.

Smith JJ, Deane NG, Wu F, Merchant NB, Zhang B, Jiang A, Lu P, Johnson JC, Schmidt C, Bailey CE, Eschrich S, Kis C, Levy S, Washington MK, Heslin MJ, Coffey RJ, Yeatman TJ, Shyr Y, Beauchamp RD.

Gastroenterology. 2010 Mar;138(3):958-68. doi: 10.1053/j.gastro.2009.11.005. Epub 2009 Nov 13.

15.

Smad7 induces hepatic metastasis in colorectal cancer.

Halder SK, Rachakonda G, Deane NG, Datta PK.

Br J Cancer. 2008 Sep 16;99(6):957-65. doi: 10.1038/sj.bjc.6604562.

16.

Regulation of metastasis in colorectal adenocarcinoma: a collision between development and tumor biology.

Smith JJ, Deane NG, Dhawan P, Beauchamp RD.

Surgery. 2008 Sep;144(3):353-66. doi: 10.1016/j.surg.2008.05.007. Epub 2008 Jul 25. Review. No abstract available.

17.

Targeted imaging of colonic tumors in smad3-/- mice discriminates cancer and inflammation.

Deane NG, Manning HC, Foutch AC, Washington MK, Aronow BJ, Bornhop DJ, Coffey RJ.

Mol Cancer Res. 2007 Apr;5(4):341-9. Erratum in: Mol Cancer Res. 2007 May;5(5):521. Aronow, Bruce A [corrected to Aronow, Bruce J].

18.

Cell proliferation: a matter of time and place.

Deane NG, Parker MA, Beauchamp RD.

Surgery. 2005 Jul;138(1):1-7. Review. No abstract available.

PMID:
16003308
19.

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD.

J Clin Invest. 2005 Jul;115(7):1765-76. Epub 2005 Jun 16.

20.

Enhanced tumor formation in cyclin D1 x transforming growth factor beta1 double transgenic mice with characterization by magnetic resonance imaging.

Deane NG, Lee H, Hamaamen J, Ruley A, Washington MK, LaFleur B, Thorgeirsson SS, Price R, Beauchamp RD.

Cancer Res. 2004 Feb 15;64(4):1315-22.

21.

Over-expression of cyclin D1 regulates Cdk4 protein synthesis.

Parker MA, Deane NG, Thompson EA, Whitehead RH, Mithani SK, Washington MK, Datta PK, Dixon DA, Beauchamp RD.

Cell Prolif. 2003 Dec;36(6):347-60.

PMID:
14710852
22.

Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.

Deane NG, Parker MA, Aramandla R, Diehl L, Lee WJ, Washington MK, Nanney LB, Shyr Y, Beauchamp RD.

Cancer Res. 2001 Jul 15;61(14):5389-95.

Supplemental Content

Loading ...
Support Center